Published in
Elsevier, Current Problems in Cardiology, 6(47), p. 100852, 2022
DOI: 10.1016/j.cpcardiol.2021.100852
Links
Tools
First-line Treatment with Empagliflozin and Metformin Combination Versus Standard Care for Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease in Qatar. A Cost-Effectiveness Analysis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 